Concurrent Session: Variables impacting outcomes after IEC
Friday, September 8, 2023 01:45 PM - 02:45 PM
Grand Ballroom L
Chair
Kevin Curran, MD, Memorial Sloan Kettering Cancer Center, USA
Speakers
Kevin Curran, MD, Memorial Sloan Kettering Cancer Center, USA – Patient Related Variables Impacting Outcome following Immune Effector Cell (IEC) therapy
Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA – Unknown Impacts of IEC Product Composition and Variability
Regina Myers, MD, Children's Hospital of Philadelphia, USA – Post-infusion Variables Impacting Outcomes After CAR T-cell Therapy for B-ALL
Lymphodepletion (including PK/exposure), cell dose/product composition, and clinical variables impacting outcomes will be discussed
Session Objectives
Kevin Curran, MD, Memorial Sloan Kettering Cancer Center, USA
Speakers
Kevin Curran, MD, Memorial Sloan Kettering Cancer Center, USA – Patient Related Variables Impacting Outcome following Immune Effector Cell (IEC) therapy
Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA – Unknown Impacts of IEC Product Composition and Variability
Regina Myers, MD, Children's Hospital of Philadelphia, USA – Post-infusion Variables Impacting Outcomes After CAR T-cell Therapy for B-ALL
Lymphodepletion (including PK/exposure), cell dose/product composition, and clinical variables impacting outcomes will be discussed
Session Objectives
- Discuss impact of pre-infusion and patient variables on outcomes following IEC therapy.
- Outline the impact of cell therapy product variability and production methodology on patient outcome following IEC therapy.
- Explore opportunities for monitoring and interventions following IEC therapy to impact outcome/durability of IEC therapy.
Kevin Curran MD
Pediatric Hematologist-Oncologist
Memorial Sloan Kettering Cancer Center
Chair and Speaker
Pediatric Hematologist-Oncologist
Memorial Sloan Kettering Cancer Center
Chair and Speaker
Sarah Nikiforow MD, PhD
Asst Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Program
Dana-Farber Cancer Institute
Speaker
Asst Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Program
Dana-Farber Cancer Institute
Speaker